Alterity Therapeutics (ASX:ATH) – Webinar Presentation
Dr David Stamler, CEO, Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
Read More